PRESS RELEASE FROM FISHAWACK HEALTH

Fishawack Health expands its global market access and HEOR capabilities with the acquisition of PRMA Consulting

Posted Mar 24, 2021

Image: (From left to right) The PRMA Consulting team is led by Jayne Sykes, Partner; David Sykes, Founding Partner; and Sotiria Papanicolaou, Partner

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEORconsulting leader with significant expertise in US, EU, and Asia-Pacific markets

March 24, 2021, UK – Leading life science commercialization partner Fishawack Health has acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the US.

The acquisition bolsters Fishawack Health’s strong strategic offering, adding deep expertise in Asia-Pacific and European markets to complement the company’s existing market access offering in North America. Fishawack Health now offers one of the industry’s leading market access and HEOR capabilities, spanning the globe.

“We’re delighted to welcome PRMA Consulting to our group – our third acquisition of 2021,” Oliver Dennis, Fishawack Health Co-founder, and CEO, said. “PRMA Consulting brings extensive global market access, HEOR, and disease area expertise, making them an important addition to our Consulting business unit. By acquiring best-in-class organizations like PRMA Consulting, we are continuously developing agile, integrated, and tailored solutions that ensure we're one step ahead of our client's complex and evolving needs across the product lifecycle – from laboratory assets to launch and beyond.”

For more than a decade, PRMA Consulting has shaped the future of market access with an industry-leading strategic offering and award-winning, cloud-based digital applications that unlock and optimize product value – the PRMA Healthcheck®, PRMA Navigator®, PRMA Tracker®, and PRMA Access Accelerator®. Fishawack Health intends to make these solutions available to all existing clients.

Fishawack Health Head of Consulting, Fred Bassett, said: “Our goal at Fishawack Health is to give clients access to highly-experienced experts who provide strategic direction, helping to make decisions that matter across the development and commercialization of portfolios, products, and services. The PRMA Consulting team shares our passion for solving the most complex and challenging healthcare problems in fast-evolving markets. We’re delighted to add a team of market access and health economics strategists with deep specialism in HEOR, healthcare technology assessments, pricing, and reimbursement processes.”

David Sykes, Founding Partner at PRMA Consulting, explained: “We are excited about the opportunity of joining Fishawack Health and building out the leading global value, evidence, and access group. We were drawn by our shared culture and values and the ability to tap into existing complementary Fishawack Health resources, which will help us provide our clients with an even better experience.

“As the pace of clinical development accelerates and the responsibilities between medical, commercial, access, and HEOR merge, we see a huge opportunity to develop market-leading integrated and cross-functional service offerings for our clients.

“We would like to thank our clients for helping us achieve this important milestone. I would also like to recognize and thank the wonderful team at PRMA Consulting who have helped us to be so successful. As our journey progresses, we remain focused on partnering with clients to help them enable faster patient access to therapies that improve health outcomes.”

About Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 950+ globe-spanning pack of strategic, creative, and scientific experts. We aim to drive change with HCPs and affect patient lives for the better.

Our three core operating units—Medical Communications, Consulting, and Commercial – bring together best-in-class capabilities from around the world. We empower our clients in global pharmaceuticals, innovative biotech, and medical devices to navigate the most complex of ecosystems while embarking on a faster, more efficient path to developing, launching, and growing their brands and portfolios.

Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, London, Manchester, and Oxford) and USA (Evansville, Minneapolis New York, Philadelphia, , San Diego, Scottsdale and St. Louis).  

Visit us at  www.fishawack.com and follow us on Twitter  and  LinkedIn.

Contact:

Natasha Cowan

Corporate Communications Manager

+44 020 3328 1840

[email protected]

Heather Brucker

Corporate Communications Manager

+1 215 837 3111

[email protected]

About PRMA Consulting

PRMA Consulting is the go-to consulting partner, using insight-based strategic consultancy and transformative digital applications to deliver smarter market access solutions. Founded in 2006, with over 100 staff across the US, Asia-Pacific, and Europe, its vision is to enable faster patient access to therapies that improve health outcomes globally.

Find out more at www.prmaconsulting.com and follow us on Twitter and LinkedIn.

Contact:

Jayne Sykes

Partner

+44 (0) 1252 786284

[email protected]

Advisers involved in this transaction included:

KPMG Manchester acted on behalf of Fishawack Health for financial and tax due diligence; Craig Scott and Elan Iorwerth, Hill Dickinson (Liverpool), together with Jamie Mercer and Lyle LeBlang, Sheppard Mullin (San Diego), and Allen & Overy (London) provided legal support; and EY provided tax advice. PricewaterhouseCoopers acted on behalf of PRMA Consulting for corporate finance. Charles Russell Speechlys LLP provided legal support and due diligence, and Marcussen Consulting LLP provided Tax advice and due diligence.